CD14 and COVID-19: Individuals recovered from severe and critical COVID-19 had reduced frequencies of plasmacytoid DCs (pDCs) and CD14+ DC3s (Bonferroni-adjusted P-value range 0.00226–3.71 × 10−7) (Fig. 4a).